Literature DB >> 30864607

Accuracy of a rapid molecular test for tuberculosis in sputum samples, bronchoalveolar lavage fluid, and tracheal aspirate obtained from patients with suspected pulmonary tuberculosis at a tertiary referral hospital.

Tatiane Maria da Silva1, Valéria Martins Soares2, Mariana Gontijo Ramos1, Adriana Dos Santos1.   

Abstract

Tuberculosis continues to be a major public health problem worldwide. The aim of the present study was to evaluate the accuracy of the Xpert MTB/RIF rapid molecular test for tuberculosis, using pulmonary samples obtained from patients treated at the Júlia Kubitschek Hospital, which is operated by the Hospital Foundation of the State of Minas Gerais, in the city of Belo Horizonte, Brazil. This was a retrospective study comparing the Xpert MTB/RIF test results with those of standard culture for Mycobacterium tuberculosis and phenotypic susceptibility tests. Although the Xpert MTB/RIF test showed high accuracy for the detection of M. tuberculosis and its resistance to rifampin, attention must be given to the clinical status of the patient, in relation to the test results, as well as to the limitations of molecular tests.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30864607      PMCID: PMC6733743          DOI: 10.1590/1806-3713/e20170451

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  13 in total

1.  Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis.

Authors:  H Y Lee; M W Seong; S S Park; S-S Hwang; J Lee; Y S Park; C H Lee; S-M Lee; C-G Yoo; Y W Kim; S K Han; J-J Yim
Journal:  Int J Tuberc Lung Dis       Date:  2013-04-23       Impact factor: 2.373

Review 2.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

3.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Cost analysis of nucleic acid amplification for diagnosing pulmonary tuberculosis, within the context of the Brazilian Unified Health Care System.

Authors:  Márcia Pinto; Aline Piovezan Entringer; Ricardo Steffen; Anete Trajman
Journal:  J Bras Pneumol       Date:  2015 Nov-Dec       Impact factor: 2.624

5.  Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients.

Authors:  John Z Metcalfe; Salome Makumbirofa; Beauty Makamure; Reggie Mutetwa; Renée A Peñaloza; Charles Sandy; Wilbert Bara; Stanley Mungofa; Philip C Hopewell; Peter Mason
Journal:  Eur Respir J       Date:  2015-03-18       Impact factor: 16.671

6.  Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid.

Authors:  Grant Theron; Jonny Peter; Richard Meldau; Hoosain Khalfey; Phindile Gina; Brian Matinyena; Laura Lenders; Gregory Calligaro; Brian Allwood; Gregory Symons; Ureshnie Govender; Mashiko Setshedi; Keertan Dheda
Journal:  Thorax       Date:  2013-06-29       Impact factor: 9.139

7.  Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis.

Authors:  Pierre Le Palud; Vincent Cattoir; Brigitte Malbruny; Romain Magnier; Karine Campbell; Youssef Oulkhouir; Gérard Zalcman; Emmanuel Bergot
Journal:  BMC Pulm Med       Date:  2014-08-12       Impact factor: 3.317

8.  Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.

Authors:  Urvashi B Singh; Pooja Pandey; Girija Mehta; Anuj K Bhatnagar; Anant Mohan; Vinay Goyal; Vineet Ahuja; Ranjani Ramachandran; Kuldeep S Sachdeva; Jyotish C Samantaray
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

9.  Molecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in Bangladesh.

Authors:  Tafsina Haque Aurin; Saurab Kishore Munshi; S M Mostofa Kamal; Md Mostafizur Rahman; Md Shamim Hossain; Thaythayhla Marma; Farjana Rahman; Rashed Noor
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

10.  Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?

Authors:  Willy Ssengooba; Durval Respeito; Edson Mambuque; Silvia Blanco; Helder Bulo; Inacio Mandomando; Bouke C de Jong; Frank G Cobelens; Alberto L García-Basteiro
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more
  3 in total

Review 1.  Value of Xpert MTB/RIF Using Bronchoalveolar Lavage Fluid for the Diagnosis of Pulmonary Tuberculosis: a Systematic Review and Meta-analysis.

Authors:  Hong-Chao Liu; Yu-Lu Gao; Dan-Feng Li; Xi-Yi Zhao; Yuan-Qing Pan; Chang-Tai Zhu
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  Tuberculosis series 2019.

Authors:  Denise Rossato Silva; Giovanni Battista Migliori; Fernanda Carvalho de Queiroz Mello
Journal:  J Bras Pneumol       Date:  2019-04-25       Impact factor: 2.624

3.  Cost-effectiveness of Xpert®MTB/RIF in the diagnosis of tuberculosis: pragmatic study.

Authors:  Suely Conceição Alves da Silva; Maria Claudia Vater; Daniela Maria de Paula Ramalho; Isabela Neves de Almeida; Silvana Spíndola de Miranda; Afrânio Kritski
Journal:  Rev Soc Bras Med Trop       Date:  2021-02-10       Impact factor: 1.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.